EarningsQ4 2020 Earnings Report

Vertex Pharmaceuticals (VRTX) Q4 2020 Earnings Report

0 Followers

MX:VRTX Q4 2020 EPS Results

Actual EPS$43.22

Consensus EPS―

Beat/Miss―

One Year Ago EPS$29.27

Actual Revenue$28.23B

Expected Revenue―

Beat/Miss―

YoY Revenue Growth+16.60%

QuarterQ4 2020

Date02/01/2021

TimeAfter Close

Conference CallMonday, February 1, 2021

MX:VRTX Upcoming Earnings

Vertex Pharmaceuticals's next earnings date is estimated for November 9, 2026, based on past reporting schedules.

No earnings call audio is available for this earnings event.

No slide deck is available for this earnings event.

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Nov 09, 2026	2026 (Q3)	81.90 / -	82.653	―
Aug 03, 2026	2026 (Q2)	81.64 / 81.45	77.832	4.65% (+3.62)
May 04, 2026	2026 (Q1)	73.06 / 76.97	69.911	10.10% (+7.06)
Feb 12, 2026	2025 (Q4)	88.01 / 86.61	68.533	26.38% (+18.08)
Nov 03, 2025	2025 (Q3)	78.74 / 82.65	75.421	9.59% (+7.23)
Aug 06, 2025	2025 (Q2)	73.84 / 77.83	-220.925	135.23% (+298.76)
May 05, 2025	2025 (Q1)	74.34 / 69.91	81.964	-14.71% (-12.05)
Feb 10, 2025	2024 (Q4)	69.15 / 68.53	72.322	-5.24% (-3.79)
Nov 04, 2024	2024 (Q3)	70.22 / 75.42	70.255	7.35% (+5.17)
Aug 01, 2024	2024 (Q2)	-200.19 / -220.93	66.984	-429.82% (-287.91)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed